Improving HPV vaccination rates in rural adolescents
Official title: Developing and piloting an intervention to reduce HPV vaccination disparities in rural adolescents
Funded at Univ of North Carolina Chapel Hill · NIH-10887284 · Data updated 2026-11-12
This study is looking at how to encourage more kids in rural North Carolina to get the HPV vaccine starting at age 9, by working with local doctors and listening to parents' thoughts on vaccinating younger children, all to help prevent cancer.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $157,744 |
| NIH project number | 1K01HS029527-01A1 |
| Project ID | NIH-10887284 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are rural adolescents aged 9 to 12 and their caregivers in North Carolina.
✕Less likely to help
Patients living in urban areas or those who are already up-to-date with their HPV vaccinations may not benefit from this research.
What this research studies
This research aims to address the low rates of HPV vaccination among adolescents in rural North Carolina by exploring the feasibility of recommending the vaccine starting at age 9. The project will work closely with healthcare providers in rural clinics to identify effective strategies for promoting early vaccination. It will also gather feedback from caregivers to understand their views on vaccinating younger children. By implementing these strategies, the research hopes to increase vaccination coverage and reduce disparities in cancer prevention.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates among rural adolescents, leading to better protection against HPV-related cancers.
How similar studies have gone: Previous research has shown that early vaccination can improve coverage rates, indicating that this approach has potential for success.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Vielot, Nadja — Univ of North Carolina Chapel Hill
- Study coordinator: Vielot, Nadja
Related research
Other NIH-funded projects on the same topics.
-
Protective dengue vaccines that steer T and B cell responses
A vaccine study aims to guide the body’s T and B cells to fight all four dengue virus types safely and effectively.
-
Respiratory pathogen–specific T cell signatures after vaccination, infection, and treatment
A research effort to map how immune T cells respond to respiratory infections and vaccines, with potential to guide better vaccines and treatments for conditions like covid-19 and pertussis.
-
Malaria vaccine and infection: how the body’s early and later immune responses relate to protection
Researchers are studying how people’s immune systems respond to the malaria pre-erythrocytic stage, whether after vaccination or infection, to identify which responses are linked to protection.
-
Spatially responsive mass vaccination for urban rabies
A new plan uses data and maps to place vaccination sites where they’re most needed in cities, aiming to boost rabies vaccination for both people and dogs.
-
Spatially responsive mass vaccination for urban rabies
A project tests smarter placement of vaccination sites to increase mass canine rabies vaccination in cities.
-
Vaccine failure after Covid-19 vaccination in older adults
This project follows vaccinated older adults to understand who among them still gets Covid-19 and what factors make those outcomes worse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.